GPC1 and urinary bladder carcinoma: In contrary, repression of GPC1 gene expression in T24 bladder carcinoma, HepG2 liver hepatocellular carcinoma and U87 brain glioma cells using CRSPR/Cas9 or siRNA resulted in significant attenuation of cancer cell proliferation indicating the potential of GPC1 as target for future cancer therapies.